Gerald Maxwell Cherf
0000-0003-4400-2414
Publication & Citation Trends
Publications
22 total
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules
Cited by 9
Semantic Scholar
An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting
Cited by 1
Semantic Scholar
Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. OA
Cited by 5
Semantic Scholar
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8 OA
Cited by 20
Semantic Scholar
CD98hc is a target for brain delivery of biotherapeutics OA
Cited by 58
Semantic Scholar
Author Correction: CD98hc is a target for brain delivery of biotherapeutics OA
Cited by 2
Semantic Scholar
De novo Design of a Highly Specific Inhibitor of Integrin Αvβ6 for Pulmonary Fibrosis
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(6)
Bladder and Urothelial Cancer Treatments
(4)
Ovarian cancer diagnosis and treatment
(4)
Parkinson's Disease Mechanisms and Treatments
(3)
Drug Transport and Resistance Mechanisms
(3)
Affiliations
University of California, Santa Cruz
Denali Therapeutics (United States)
Stanford Medicine
Bioengineering Center
Stanford University